NM_021098.3:c.1508G>A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_021098.3(CACNA1H):​c.1508G>A​(p.Arg503His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000144 in 1,545,504 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R503C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00043 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00011 ( 1 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 1.89

Publications

1 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.023483157).
BP6
Variant 16-1201958-G-A is Benign according to our data. Variant chr16-1201958-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 460048.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000433 (66/152288) while in subpopulation AFR AF = 0.0013 (54/41556). AF 95% confidence interval is 0.00102. There are 0 homozygotes in GnomAd4. There are 26 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 66 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.1508G>A p.Arg503His missense_variant Exon 9 of 35 ENST00000348261.11 NP_066921.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.1508G>A p.Arg503His missense_variant Exon 9 of 35 1 NM_021098.3 ENSP00000334198.7
CACNA1HENST00000569107.6 linkc.1508G>A p.Arg503His missense_variant Exon 9 of 34 1 ENSP00000454990.2
CACNA1HENST00000711493.1 linkc.1508G>A p.Arg503His missense_variant Exon 9 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.1508G>A p.Arg503His missense_variant Exon 9 of 34 1 ENSP00000455840.1
CACNA1HENST00000711450.1 linkc.1508G>A p.Arg503His missense_variant Exon 9 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.1508G>A p.Arg503His missense_variant Exon 9 of 35 1 ENSP00000457555.2
CACNA1HENST00000638323.1 linkc.1469G>A p.Arg490His missense_variant Exon 9 of 35 5 ENSP00000492267.1
CACNA1HENST00000562079.6 linkc.1508G>A p.Arg503His missense_variant Exon 9 of 34 1 ENSP00000454581.2
CACNA1HENST00000711438.1 linkc.1469G>A p.Arg490His missense_variant Exon 9 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.1508G>A p.Arg503His missense_variant Exon 9 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.1508G>A p.Arg503His missense_variant Exon 9 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.1508G>A p.Arg503His missense_variant Exon 9 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.1508G>A p.Arg503His missense_variant Exon 9 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.1508G>A p.Arg503His missense_variant Exon 9 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.1508G>A non_coding_transcript_exon_variant Exon 9 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.1508G>A non_coding_transcript_exon_variant Exon 9 of 34 5 ENSP00000492650.2
CACNA1HENST00000639478.1 linkn.1508G>A non_coding_transcript_exon_variant Exon 9 of 35 5 ENSP00000491945.1
CACNA1HENST00000711442.1 linkn.*955G>A non_coding_transcript_exon_variant Exon 8 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.1508G>A non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.1508G>A non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.1508G>A non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.1508G>A non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.1508G>A non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.1508G>A non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.1508G>A non_coding_transcript_exon_variant Exon 9 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.1508G>A non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.1508G>A non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518777.1
CACNA1HENST00000711442.1 linkn.*955G>A 3_prime_UTR_variant Exon 8 of 34 ENSP00000518758.1
CACNA1HENST00000640028.1 linkn.1385+123G>A intron_variant Intron 9 of 34 5 ENSP00000491488.1

Frequencies

GnomAD3 genomes
AF:
0.000434
AC:
66
AN:
152172
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00130
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000844
AC:
12
AN:
142242
AF XY:
0.0000261
show subpopulations
Gnomad AFR exome
AF:
0.00136
Gnomad AMR exome
AF:
0.0000409
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000192
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000112
AC:
156
AN:
1393216
Hom.:
1
Cov.:
36
AF XY:
0.0000976
AC XY:
67
AN XY:
686594
show subpopulations
African (AFR)
AF:
0.00143
AC:
45
AN:
31488
American (AMR)
AF:
0.000112
AC:
4
AN:
35592
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25098
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35626
South Asian (SAS)
AF:
0.0000253
AC:
2
AN:
79118
European-Finnish (FIN)
AF:
0.0000216
AC:
1
AN:
46242
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5536
European-Non Finnish (NFE)
AF:
0.0000854
AC:
92
AN:
1076708
Other (OTH)
AF:
0.000208
AC:
12
AN:
57808
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
11
21
32
42
53
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000433
AC:
66
AN:
152288
Hom.:
0
Cov.:
34
AF XY:
0.000349
AC XY:
26
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.00130
AC:
54
AN:
41556
American (AMR)
AF:
0.000131
AC:
2
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68010
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0336
Hom.:
909
Bravo
AF:
0.000480
ESP6500AA
AF:
0.000563
AC:
2
ESP6500EA
AF:
0.000279
AC:
2
ExAC
AF:
0.000108
AC:
6

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
-
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNA1H NM_021098.2 exon 9 p.Arg503His (c.1508G>A): This variant has not been reported in the literature but is present in 0.1% (16/15288) of African alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/16-1251958-G-A). This variant is present in ClinVar (Variation ID:460048). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

Inborn genetic diseases Uncertain:1
Jul 15, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1508G>A (p.R503H) alteration is located in exon 9 (coding exon 8) of the CACNA1H gene. This alteration results from a G to A substitution at nucleotide position 1508, causing the arginine (R) at amino acid position 503 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Feb 08, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 35668055) -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Dec 07, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.10
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.19
T;.;.;.
Eigen
Benign
0.014
Eigen_PC
Benign
-0.13
FATHMM_MKL
Benign
0.66
D
LIST_S2
Benign
0.85
T;T;T;.
M_CAP
Uncertain
0.25
D
MetaRNN
Benign
0.023
T;T;T;T
MetaSVM
Uncertain
0.27
D
MutationAssessor
Uncertain
2.0
M;.;M;M
PhyloP100
1.9
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-1.5
N;.;N;N
REVEL
Uncertain
0.30
Sift
Benign
0.095
T;.;T;T
Sift4G
Benign
0.16
T;.;T;T
Polyphen
1.0
D;.;D;D
Vest4
0.23
MVP
0.88
ClinPred
0.021
T
GERP RS
2.6
Varity_R
0.090
gMVP
0.35
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201009269; hg19: chr16-1251958; COSMIC: COSV100673409; COSMIC: COSV100673409; API